Skip to content

Advertisement

In Review

See your manuscript’s review progress with our first-of-its-kind In Review service

Our commitment to research in progress and openness inspires us to think about how to help our authors in new ways. So, together with our partners at Research Square, we’ve added a new option for you when you submit to BMC Anesthesiology, BMC Neurology, BMC Ophthalmology, or Trials. This new option, called In Review, gives you insight over your manuscript’s editorial progress; even while it’s out for review. 

With In Review you can:

  • Track the status of your manuscript, including getting immediate access to reviewer reports as they come in
  • Share your work with funders and others in a citeable way while it is under review, and engage the wider community in discussion to help make your article even better including through the Hypothes.is open annotation tool
  • Demonstrate the integrity of your work with a transparent editorial checklist
  • Benefit from early sharing, such as more collaboration opportunities and earlier citations

Your peers will be able to: 

  • Comment on/see emerging science in full HTML format
  • Find new discoveries with fully-indexed search
  • Note which editorial checks the manuscript has already passed
  • Gain insight into the peer review pipeline of particular manuscripts at the given journals

How can I participate in In Review?

It's simple! Just select the In Review option when you submit your next article to one of the four participating journals. 

How will the peer review process differ if you opt in?

The reviews and editor communications will continue through the Editorial Manager site as usual. You can use In Review to access up to date information on where your article is in the peer review process. In addition, others will be able to follow the status of your manuscript during peer review, such as whether it is “out for review” or the number of reviewer reports received. Through a private author portal, you will also have access to reviewer reports as and when they come in.

Your manuscript will also be posted immediately to In Review and will receive a citeable DOI. The community will be able to comment on, read, or cite your manuscript using the platform. Authors could take any substantive comments into account during the peer review process in order to strengthen their findings. 

What can you expect after opting in?

1. Opt In

When you submit your article through Editorial Manager as usual you will be given the chance to opt in to this new service.

2. Editorial checks

If you choose to opt in your paper will undergo some basic editorial checks before being sent to the in review platform.

3. Article depositing

Our partners Research Square, who host this platform, will then convert it to html, assign a DOI and post it on their site under a CC-BY license. At this point, it is made public—anyone can view this version.

4. Email notification

Once posted, you will receive a notification from Research Square to inform you that the paper is now available for viewing. This will include a link to your author dashboard, where you will be asked to create a password before logging in.

5. Dashboard acccess

Your author dashboard will give you more information than is made available to readers, including a full peer review timeline, sharing functionality and an ability to suggest reviewers

6. Real time updates

As your paper progresses through the editorial process, your dashboard will provide you with real time information, such as when reviewers have been invited and accepted. You can also see reviews and community comments as they come in.

7. Final decision

If your paper is rejected, all information corresponding to the journal will be removed. You are free to send the link to this version to other journals as part of a future submission. If accepted, your paper will be formally published in the journal,
along with its peer review history.

Frequently asked questions

What is In Review?

Powered by Research Square and developed in partnership with BMC, In Review aims to open up the peer review process to authors and beyond. The first service of its kind, In Review will provide authors with on-demand access to the status of their manuscript on a more granular level, including number of reviewers invited, number of reports received, and immediate access to reviewer reports. In Review will also allow authors to showcase their work to funders and others and to engage the wider community for comment and collaboration while their manuscript is under review, allowing authors to benefit from early sharing, including potential earlier citations and collaboration opportunities.

Why is BMC piloting In Review and what is the benefit to the community and to authors?

Experimenting with new initiatives to improve the peer review process and to advance research has been something we have long championed at BMC. Through In Review we aim to give added visibility to potentially significant science that is being considered for publication and to encourage wider involvement by the community. We anticipate this early sharing will help authors to strengthen their manuscripts as well as spur collaboration opportunities.

By using In Review authors will be able to:

  • Showcase their work to funders and others in a citeable way while it is under review and engage the wider community in discussion to improve their article (including through the Hypothes.is open annotation tool)
  • Track the status of their manuscript on a more granular level -- including number of reviewers invited, number of reports received, and immediate access to reviewer reports
  • Demonstrate the integrity of their work with a transparent editorial checklist
  • Benefit from early sharing, such as more collaboration opportunities and earlier citations.

The wider research community will be able to:

  • Comment on/see emerging science in full html format
  • Find new discoveries with fully-indexed search
  • Note which editorial checks the manuscript has already passed
  • Gain insight into the peer review pipeline of particular manuscripts at the given journals.

What journals will be using In Review?

The journals are: Trials, BMC Anesthesiology, BMC Ophthalmologyand BMC Neurology.

What does it mean when I opt in to In Review?

The reviews and editor communications will continue through the Editorial Manager site as usual. You can use In Review to access up to date information on where your article is in the peer review process at a granular level (eg, number of reviewers invited, number of reviewers agreed). In addition, others will be able to follow the status of your manuscript during peer review, such as whether it is “out for review” or the number of reviewer reports received. Through a private author dashboard, you will also have access to reviewer reports as and when they come in.

Your manuscript will also be posted immediately to In Review and will receive a citeable DOI. The community will be able to comment on, read, or cite your manuscript using the platform. Authors could take any substantive comments into account during the peer review process in order to strengthen their findings.

Please note that whether or not you opt in to this service will not affect the ultimate decision on whether your manuscript is accepted. However, if you do decide to opt in, the journal Editor may choose to take community comments into account.

Will the editor take into consideration any comments made on my manuscript on In Review?

Editors may choose to take commenting through the Research Square platform into consideration. As with traditional review, they will rely on reviewers with field expertise in forming their decision.

Does my decision to participate have any impact on the editorial decisions made by the journal?

Opting in or not will have no effect on the ultimate decision on whether your manuscript is accepted.

How do I submit a revised version of my article to In Review?

To submit a revision, you will need to submit through Editorial Manager. In Review only posts versions of your manuscript currently being considered by the journal.

Can I post my manuscript on a preprint server as well?

When you post to a preprint server you retain full copyright over your article, and you are therefore free to post it in as many places as you like. However, having more than one version in different places could reduce the usage counts and metrics obtained here and on the other sites, and may cause confusion to some readers.

How are submissions to In Review checked before posting?

Submissions to In Review undergo a quality control check. These include checking for:

  • Third party rights
  • Data availability
  • Plagiarism
  • Biosecurity
  • Ethics approval
  • Trial registration
  • Competing interests
  • Funding information

Is there a charge for participating in In Review?

There is no charge for participating in In Review.

What will happen to my manuscript on Research Square if my article is rejected from the journal I submitted to?

If your article is rejected, all information corresponding to the journal will be removed, leaving only the article and any revisions that have been submitted. You are free to send the link to this version to other journals as part of a future submission.

Terms and Conditions

Terms and conditions

In opting in to In Review and the Research Square platform I certify that;

  1. I am authorized by my co-authors to enter into these arrangements
  2. All authors of the manuscript have agreed to post all versions of the submission on the Research Square platform during the peer review process
  3. I warrant, on behalf of myself and my co-authors, that:
    1. the article does not infringe any existing copyright or any other third party rights;
    2. I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting the rights to Research Square R&D LLC are not in breach of any other obligation;
    3. the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
    4. I/we have taken due care to ensure the integrity of the article. To my/our—and currently accepted scientific—knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage.
  4. I, and all co-authors, agree that the article shall be licensed under the Creative Commons Attribution License 4.0 on the Research Square platform. If the law requires that the article be published in the public domain, I/we will notify Research Square at the time of submission, and in such cases not only the data but also the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.

Contact us: 

For questions about your submission at the journal and this pilot​​​​​​​:

info@biomedcentral.com

For questions about your manuscript on the Research Square platform:

info@researchsquare.com​​​​​​​